돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1046039생성일: 2026년 10월 24일

N,N'-dicyclohexyl-4-morpholinecarboxamidine → Hexadecyloxypropyl-cyclic cidofovir

https://huagongshe.com/ko/reaction/1046039

반응식

참여 물질

역할이름HCID투입량
반응물N,N'-dicyclohexyl-4-morpholinecarboxamidineHCID 21079—
반응물Cyclic HPMPCHCID 122873—
반응물1-(3-Bromopropoxy)hexadecaneHCID 14654645—
생성물Hexadecyloxypropyl-cyclic cidofovirHCID 48347425%

반응 조건

온도80 °C

반응 단계

To a heterogeneous solution of cyclic cidofovir (39 g, 0.131 mol., 1 equiv, purchased from Gilead Sciences) in N,N-DMF (2.0 L) under a nitrogen atmosphere was added N,N′-dicyclohexyl-4-morpholinecarboxamidine (DCMC) (0.131 mol, 38.51 g, 1 equiv.). This was stirred overnight. This dissolved most of the solid in the reaction mixture. To this solution was added 1-bromo-3-hexadecyloxypropane (238.45 g, 0.656 mol, 5 equiv.). The reaction mixture was heated to 80° C. and stirred for 6 hours. The crude reaction mixture was concentrated in vacuo at 80° C. The crude reaction mixture was absorbed on silica gel (300 g) and purified via column chromatography (800 g SiO2). The column was eluted with dichloromethane (6 L) to remove the excess 1-bromo-3-hexadecyloxypropane. The solvent phase was then switched to 9:1 CH2Cl2:EtOH(32 L). The product came off with this solvent system. Fractions 30-39 were combined to give hexadecyloxypropyl-cyclic cidofovir (17.8 g) in a 25% yield.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08569321B2
출처 데이터셋uspto-grants-2013_10
ORD IDord-a6ed0e351dab465db1d4bee281aa96a1
출처 메모uspto-grants-2013_10